87 related articles for article (PubMed ID: 7995740)
1. Conventional four-field pelvic radiotherapy technique without computed tomography-treatment planning in cancer of the cervix: potential geographic miss and its impact on pelvic control.
Kim RY; McGinnis LS; Spencer SA; Meredith RF; Jennelle RL; Salter MM
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):109-12. PubMed ID: 7995740
[TBL] [Abstract][Full Text] [Related]
2. Conventional four-field pelvic radiotherapy technique without CT treatment planning in cancer of the cervix: potential geographic miss.
Kim RY; McGinnis LS; Spencer SA; Meredith RF; Jennelle RL; Salter MM
Radiother Oncol; 1994 Feb; 30(2):140-5. PubMed ID: 8184111
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
4. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks.
Finlay MH; Ackerman I; Tirona RG; Hamilton P; Barbera L; Thomas G
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):205-9. PubMed ID: 16198505
[TBL] [Abstract][Full Text] [Related]
5. Clinical tumor dimensions may be useful to prevent geographic miss in conventional radiotherapy of uterine cervix cancer-a magnetic resonance imaging-based study.
Justino PB; Baroni R; Blasbalg R; Carvalho Hde A
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):503-10. PubMed ID: 18947939
[TBL] [Abstract][Full Text] [Related]
6. Conventional 4-field box radiotherapy technique for cancer cervix: potential for geographic miss without CECT scan-based planning.
Nagar YS; Singh S; Kumar S; Lal P
Int J Gynecol Cancer; 2004; 14(5):865-70. PubMed ID: 15361196
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging in the treatment planning of radiation therapy in carcinoma of the cervix treated with the four-field pelvic technique.
Thomas L; Chacon B; Kind M; Lasbareilles O; Muyldermans P; Chemin A; Le Treut A; Pigneux J; Kantor G
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):827-32. PubMed ID: 9128958
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
[TBL] [Abstract][Full Text] [Related]
11. Anatomic study of the pelvis in carcinoma of the uterine cervix as related to the box technique.
Zunino S; Rosato O; Lucino S; Jauregui E; Rossi L; Venencia D
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):53-9. PubMed ID: 10219794
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of geographic miss when using conventional four field radiotherapy technique in treatment of locally advanced carcinoma cervix.
Gulia A; Patel FD; Santam C; Bhavana R; Reena K; Sharma SC
Indian J Cancer; 2016; 53(1):80-5. PubMed ID: 27146749
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pelvic lymph node coverage of conventional radiotherapy fields based on bony landmarks in Chinese cervical cancer patients using CT simulation.
Zhang X; Yu H
J Zhejiang Univ Sci B; 2009 Sep; 10(9):683-8. PubMed ID: 19735101
[TBL] [Abstract][Full Text] [Related]
14. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
[TBL] [Abstract][Full Text] [Related]
15. Reduction of late complications after irregularly shaped four-field whole pelvic radiotherapy using computed tomographic simulation compared with parallel-opposed whole pelvic radiotherapy.
Yamazaki A; Shirato H; Nishioka T; Hashimoto S; Kitahara T; Kagei K; Miyasaka K
Jpn J Clin Oncol; 2000 Apr; 30(4):180-4. PubMed ID: 10830986
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
19. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
